vTv Therapeutics (VTVT) Assets Average (2015 - 2026)

vTv Therapeutics (VTVT) has 12 years of Assets Average data on file, last reported at $94.4 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 168.46% year-over-year to $94.4 million; the trailing twelve-month figure through Mar 2026 stood at $94.4 million (up 168.46% YoY), and the FY2025 full-year result was $64.1 million, up 160.05% from the prior year.
• Assets Average was little changed at $94.4 million in Q1 2026, from $94.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $94.7 million in Q4 2025 to a low of $13.0 million in Q4 2023.
• A 5-year average of $40.9 million and a median of $34.4 million in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average tumbled 62.27% in 2023 and jumped 213.89% in 2024, its largest moves.
• Tracing VTVT's Assets Average over 5 years: stood at $34.4 million in 2022, then plunged by 62.27% to $13.0 million in 2023, then jumped by 213.89% to $40.7 million in 2024, then soared by 132.58% to $94.7 million in 2025, then fell by 0.36% to $94.4 million in 2026.
• Business Quant data shows VTVT's Assets Average at $94.4 million in Q1 2026, $94.7 million in Q4 2025, and $63.0 million in Q3 2025.